These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


230 related items for PubMed ID: 9530568

  • 1. [Supraventricular tachyarrhythmias. Cardiac, extra-cardiac and arrhythmogenic side effects of anti-arrhythmia drugs].
    Meinertz T, Willems S, Weiss C.
    Internist (Berl); 1998 Jan; 39(1):33-7. PubMed ID: 9530568
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Magnesium as an anti-arrhythmic therapy principle in supraventricular and ventricular cardiac arrhythmias].
    Zehender M.
    Z Kardiol; 1996 Jan; 85 Suppl 6():135-45. PubMed ID: 9064958
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. After a long time, the new ESC Guidelines for the management of patients with supraventricular tachycardia are here.
    Tamargo J.
    Eur Heart J Cardiovasc Pharmacother; 2020 Jan 01; 6(1):3-5. PubMed ID: 31800023
    [No Abstract] [Full Text] [Related]

  • 6. [Cardiology update--I].
    Trappe HJ, Pfitzner P.
    Med Klin (Munich); 1996 Apr 01; 91 Suppl 1():118-27. PubMed ID: 8657078
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Risks and side effects in treatment of supraventricular tachycardia].
    Lüderitz B.
    Z Gesamte Inn Med; 1993 Sep 01; 48(9):459-65. PubMed ID: 8212752
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Variants of arrhythmogenic action of anti-arrhythmia agents identified during choice of therapy by a transesophageal electrophysiological study].
    Rychkov AIu, Shurin MS, Shakhov GG.
    Kardiologiia; 1993 Sep 01; 33(1):87-9. PubMed ID: 8035557
    [No Abstract] [Full Text] [Related]

  • 12. [Perioperative management of cardiac arrhythmia: part II].
    Zaballos García M, López Berlanga JL, Navia Roque J.
    Rev Esp Anestesiol Reanim; 2006 Mar 01; 53(3):163-83; quiz 183, 193. PubMed ID: 16671260
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Magnesium: current studies--critical evaluation--consequences].
    Meinertz T.
    Z Kardiol; 1996 Mar 01; 85 Suppl 6():147-51. PubMed ID: 9064959
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antiarrhythmic drugs for supraventricular tachycardia.
    Wellens HJ, Brugada P, Smeets JL.
    Am J Cardiol; 1988 Dec 20; 62(19):69L-73L. PubMed ID: 3059790
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Arrhythmogenic effect of anti-arrhythmia drugs].
    Trusz-Gluza M.
    Kardiol Pol; 1991 Dec 20; 34(1):41-8. PubMed ID: 2051713
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.